Clinical Trials Logo

General Movement Assessment clinical trials

View clinical trials related to General Movement Assessment.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04555915 Completed - Clinical trials for General Movement Assessment

General Movement Assessment - Ancillary Study to SafeBoosC III Trial

GMASafeboosC
Start date: July 1, 2020
Phase:
Study type: Observational

In course of the SafeBoosC III trial, we would like to analyse routinely performed GMA as secondary outcome parameter in an ancillary observational study. First aim is to analyse in surviving neonates included into the SafeboosC III trial any differences between the experimental group group and control group in Global-GMA at term age. Second aim is to investigate GMOS at term age and if available GMA at 9-16 weeks corrected age.